Rational and design of SATRACD study: detecting subclinical anthracycline therapy related cardiac dysfunction in low income country

BACKGROUND: Anthracycline therapy-related cardiac dysfunction (ATRCD) is the most notorious adverse side-effect of chemotherapy. It has become a significant cardiovascular health concern for long-term cancer survivors. With the emerging concept of subclinical ATRCD and newer diagnostictools (Speckle...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wanzhu, Azibani, Feriel, Okello, Emmy, Kayima, James, Walusansa, Victoria, Orem, Jackson, Sliwa, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Makerere Medical School 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568225/
https://www.ncbi.nlm.nih.gov/pubmed/34795719
http://dx.doi.org/10.4314/ahs.v21i2.21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568225/
https://www.ncbi.nlm.nih.gov/pubmed/34795719
http://dx.doi.org/10.4314/ahs.v21i2.21

Ejemplares similares